Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
OxyNorm liquid 5mg/5ml oral solution
0407020ADBBAAAA
|
OxyNorm | Oxycodone hydrochloride | Central Nervous System | 12,076 |
|
OxyNorm 5mg capsules
0407020ADBBACAC
|
OxyNorm | Oxycodone hydrochloride | Central Nervous System | 2,964 |
|
OxyNorm 10mg capsules
0407020ADBBADAD
|
OxyNorm | Oxycodone hydrochloride | Central Nervous System | 2,014 |
|
OxyNorm 20mg capsules
0407020ADBBAEAE
|
OxyNorm | Oxycodone hydrochloride | Central Nervous System | 795 |
|
OxyNorm 10mg/ml concentrate oral solution
0407020ADBBABAB
|
OxyNorm | Oxycodone hydrochloride | Central Nervous System | 760 |
|
OxyNorm 10mg/1ml solution for injection ampoules
0407020ADBBAFAL
|
OxyNorm | Oxycodone hydrochloride | Central Nervous System | 154 |
|
OxyNorm 20mg/2ml solution for injection ampoules
0407020ADBBAGAM
|
OxyNorm | Oxycodone hydrochloride | Central Nervous System | 30 |
|
OxyNorm 50mg/1ml solution for injection ampoules
0407020ADBBAHAN
|
OxyNorm | Oxycodone hydrochloride | Central Nervous System | 12 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.